首页|期刊导航|Cancer Innovation|Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia

Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia

Seiichi Okabe Yuya Arai Akihiko Gotoh Daigo Akahane

Cancer Innovation2025，Vol.4Issue(5)：P.112-122,11.

Cancer Innovation2025，Vol.4Issue(5)：P.112-122,11.DOI:10.1002/cai2.70024

Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia

Seiichi Okabe ¹Yuya Arai ¹Akihiko Gotoh ¹Daigo Akahane¹

作者信息

1. Department of Hematology,Tokyo Medical University,Tokyo,Japan
折叠

摘要

关键词

chronic myeloid leukemia/vitamin K2/WEE1 inhibitor

分类

医药卫生

引用本文复制引用

Seiichi Okabe,Yuya Arai,Akihiko Gotoh,Daigo Akahane..Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia[J].Cancer Innovation,2025,4(5):P.112-122,11.

Cancer Innovation

ISSN：2770-9191

访问量0

下载量0

段落导航